Leukocyte Immunoglobulin-Like Receptors as New Players in Autoimmunity

被引:29
|
作者
Thomas, Rachel [1 ]
Matthias, Torsten [2 ]
Witte, Torsten [1 ]
机构
[1] Hannover Med Sch, Klin Immunol & Rheumatol, D-30625 Hannover, Germany
[2] Aesku Diagnost, D-55234 Wendelsheim, Germany
关键词
Leukocyte immunoglobulin-like receptors; Immunoglobulin-like transcripts; Autoimmunity; T-CELL RESPONSES; CLASS-I; INHIBITORY RECEPTOR; DENDRITIC CELLS; HLA-G; ASSOCIATION; ILT2; EXPRESSION; ANTIGEN; CANCER;
D O I
10.1007/s12016-009-8148-8
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Leukocyte immunoglobulin-like receptors (LILR) are a family of at least 13 receptors mainly expressed on lymphoid and myelomonocytic cells. They are involved in the activation of the immune system. Inhibitory LILR (termed LILRB) signal through immunoreceptor tyrosine-based inhibitory motives in the cytoplasmic domain, whereas LILRA with short cytoplasmic domains are stimulatory receptors. Polymorphisms and deletions of leukocyte immunoglobulin-like receptors have been shown to be associated with autoimmune disorders, and some of the receptors are involved in the generation of regulatory T cells. Therefore, leukocyte immunoglobulin-like receptors may be central in the pathogenesis of autoimmunity. The data linking these receptors to autoimmune diseases is reviewed here.
引用
收藏
页码:159 / 162
页数:4
相关论文
共 50 条
  • [21] Killer Immunoglobulin-like Receptors and Tumor Immunity
    Benson, Don M., Jr.
    Caligiuri, Michael A.
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (02) : 99 - 104
  • [22] The Role of Leukocyte Immunoglobulin-Like Receptors Focusing on the Therapeutic Implications of the Subfamily B2
    Hu, Yanyu
    Lu, Xin
    Qiu, Weimin
    Liu, Hui
    Wang, Qinghua
    Chen, Yao
    Liu, Wenyuan
    Feng, Feng
    Sun, Haopeng
    CURRENT DRUG TARGETS, 2022, 23 (15) : 1430 - 1452
  • [23] Killer cell immunoglobulin-like receptors in exercise
    Maltseva, Diana V.
    Sakharov, Dmitry A.
    Tonevitsky, Evgeny A.
    Northoff, Hinnak
    Tonevitsky, Alexander G.
    EXERCISE IMMUNOLOGY REVIEW, 2011, 17 : 150 - 163
  • [24] Leukocyte immunoglobulin-like receptors in human diseases: an overview of their distribution, function, and potential application for immunotherapies
    Zhang, Jilu
    Mai, Sunny
    Chen, Hui-Ming
    Kang, Kyeongah
    Li, Xian Chang
    Chen, Shu-Hsia
    Pan, Ping-Ying
    JOURNAL OF LEUKOCYTE BIOLOGY, 2017, 102 (02) : 351 - 360
  • [25] Evidence for natural selection on leukocyte immunoglobulin-like receptors for HLA class I in Northeast Asians
    Hirayasu, Kouyuki
    Ohashi, Jun
    Tanaka, Hidenori
    Kashiwase, Koichi
    Ogawa, Atsuko
    Takanashi, Minoko
    Satake, Masahiro
    Jia, Guan Jun
    Chimge, Nyam-Osor
    Sideltseva, Elena W.
    Tokunaga, Katsushi
    Yabe, Toshio
    AMERICAN JOURNAL OF HUMAN GENETICS, 2008, 82 (05) : 1075 - 1083
  • [26] Expression of activating and inhibitory leukocyte immunoglobulin-like receptors in rheumatoid synovium: correlations to disease activity
    Tedla, N.
    An, H.
    Borges, L.
    Vollmer-Conna, U.
    Bryant, K.
    Geczy, C.
    McNeil, H. Patrick
    TISSUE ANTIGENS, 2011, 77 (04): : 305 - 316
  • [28] Genomic organization of the human leukocyte immunoglobulin-like receptors within the leukocyte receptor complex on Chromosome 19q13.4
    Liu, WR
    Kim, J
    Nwankwo, C
    Ashworth, LK
    Arm, JP
    IMMUNOGENETICS, 2000, 51 (8-9) : 659 - 669
  • [29] Genetic epistasis between killer immunoglobulin-like receptors and human leukocyte antigens in Kawasaki disease susceptibility
    Bossi, G.
    Mannarino, S.
    Pietrogrande, M. C.
    Salice, P.
    Dellepiane, R. M.
    Cremaschi, A. L.
    Corana, G.
    Tozzo, A.
    Capittini, C.
    De Silvestri, A.
    Tinelli, C.
    Pasi, A.
    Martinetti, M.
    GENES AND IMMUNITY, 2015, 16 (07) : 481 - 487
  • [30] Killer immunoglobulin-like receptors/human leukocyte antigen class -I, a crucial immune pathway in cancer
    Xu, Yi
    Wang, Lei
    Li, Wei
    Chen, Bin
    Liu, Yu
    Wang, Hao
    Zhao, Sha
    Ye, Lingyun
    He, Yayi
    Zhou, Caicun
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (05)